Regulatory document
Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm…
CDSCO · Information · India
Key facts
| Title | Permission for conducting a clinical study entitled "A Phase-l/ll open label, single arm study to evaluate the pharmacokinetic, safety and tolerability of Delamanid in combination with optimized Multidrug Background Regimen (OBR) for multidrug-Resistant Tuberculosis (MDRTB) in HIV infected and HIV-uninfected children with MDR-TB" |
|---|---|
| Issuer | Central Drugs Standard Control Organization |
| Source | CDSCO |
| Document type | Information |
| Country or region | India |
| Document | cdsco.gov.in |
| Issuer website | cdsco.gov.in |
At a glance
- Yes Full text searchable in Orca1
- 1,000+ Documents from this issuer in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Global regulations and guidance
Regulations, guidance and official notices from medical device and medicines regulators worldwide, collected by Orca1 from each issuer's website. Only the title, issuer, date and link are shown here; the full text is searchable in Orca1.